06:48 EST BioNTech sees FY23 Covid-19 vaccine revenue ~EUR 4B vs. prior view ~EUR 5B
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BNTX:
- BioNTech (NASDAQ:BNTX) Rises After Q3 Numbers
- BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
- Biontech Se Sponsored Adr (BNTX) Q3 Earnings Cheat Sheet
- Mixed Day for Vaccine Stocks as Terrible News Emerges
- Pfizer, BioNTech announce ‘positive’ topline data for combo flu/COVID vaccine